[News Brief] Formosa Pharma Signs Licensing Deal With Samil Pharmaceutical
Formosa Pharmaceuticals, Inc. has entered into an exclusive licensing agreement with Samil Pharmaceutical Co., Ltd. for the commercialisation of an…
Pharmaceuticals & Supplements
[News Brief] Simcere Pharma Enters Research Collaboration With Stanford Medicine
Simcere Pharmaceutical Group Limited has entered a research collaboration with Stanford University School of Medicine to develop potential treatments for…
[News Brief] Mabwell Completes Dual Listing on Hong Kong Stock Exchange
Mabwell has completed a dual primary listing on the Main Board of the Hong Kong Stock Exchange following its earlier…
[News Brief] Legend Biotech to Present LB2501 Data at EHA 2026
Legend Biotech Corporation has announced that it will present preliminary Phase 1 clinical data for its investigational LB2501 therapy during…
[News Brief] LongBio Pharma Lists on Hong Kong Stock Exchange
LongBio Pharma has listed its shares on the Main Board of the Hong Kong Stock Exchange following its initial public…
[News Brief] Hanmi Pharma Partners with Organon for Southeast Asia
Hanmi Pharmaceutical has entered into a supply agreement with Organon to export three combination medicines for the Malaysian and Philippine…
[News Brief] Lundbeck Receives South Korean Authorisation for Vyepti
H. Lundbeck A/S has received marketing authorisation from South Korea’s Ministry of Food and Drug Safety (MFDS) for Vyepti (eptinezumab)…
[News Brief] CordenPharma Agrees to Acquire AmbioPharm
CordenPharma has entered into an agreement to acquire AmbioPharm, a US-headquartered contract development and manufacturing organisation (CDMO), to expand its…
[News Brief] Samsung Bioepis Launches Ustekinumab Biosimilar in Japan
Samsung Bioepis, a South Korea-based company, has launched its ustekinumab biosimilar in Japan through its partnership with Nipro Corporation, expanding…
[News Brief] Hyundai Bioscience Prepares Antiviral Supply for Outbreaks
South Korea-based Hyundai Bioscience has announced its readiness to supply its broad-spectrum antiviral drug XAFTY® in the event of Ebola…